Skip to content

Clinical trials

Phase 1/2 Breast Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 1/2 Country / region: France Clear all

66 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20072
20083
20093
20104
20113
20123
20131
20145
20151
20163
20174
20185
20194
20204
20211
20222
20233
20246
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Recruiting12
Terminated12
Active, not recruiting10
Unknown status3
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
AstraZeneca5
Eli Lilly and Company3
Hoffmann-La Roche3
Institut Paoli-Calmettes3
Puma Biotechnology, Inc.3
Sanofi3
Pfizer2
Stemline Therapeutics, Inc.2
Arno Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms66
Neoplasm Metastasis9
Carcinoma, Non-Small-Cell Lung8
Neoplasms7
Ovarian Neoplasms7
Triple Negative Breast Neoplasms7
Head and Neck Neoplasms6
Colorectal Neoplasms5
Endometrial Neoplasms5
Lung Neoplasms5

Trials

Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.